These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 7518514

  • 41. The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.
    Rodrigues AD, Ferrero JL, Amann MT, Rotert GA, Cepa SP, Surber BW, Machinist JM, Tich NR, Sullivan JP, Garvey DS.
    Drug Metab Dispos; 1994; 22(5):788-98. PubMed ID: 7530622
    [Abstract] [Full Text] [Related]

  • 42. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
    Puttfarcken PS, Manelli AM, Arneric SP, Donnelly-Roberts DL.
    J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
    [Abstract] [Full Text] [Related]

  • 43. ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity.
    Brioni JD, Kim DJ, Brodie MS, Decker MW, Arneric SP.
    Psychopharmacology (Berl); 1995 Jun; 119(4):368-75. PubMed ID: 7480515
    [Abstract] [Full Text] [Related]

  • 44. A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand.
    Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP.
    Neuropharmacology; 1996 Jun; 35(6):725-34. PubMed ID: 8887981
    [Abstract] [Full Text] [Related]

  • 45. Release-enhancing pre-synaptic muscarinic and nicotinic receptors co-exist and interact on dopaminergic nerve endings of rat nucleus accumbens.
    Grilli M, Patti L, Robino F, Zappettini S, Raiteri M, Marchi M.
    J Neurochem; 2008 Jun 01; 105(6):2205-13. PubMed ID: 18298664
    [Abstract] [Full Text] [Related]

  • 46. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors.
    Bencherif M, Schmitt JD, Bhatti BS, Crooks P, Caldwell WS, Lovette ME, Fowler K, Reeves L, Lippiello PM.
    J Pharmacol Exp Ther; 1998 Mar 01; 284(3):886-94. PubMed ID: 9495846
    [Abstract] [Full Text] [Related]

  • 47. ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeys.
    Decker MW, Bannon AW, Curzon P, Gunther KL, Brioni JD, Holladay MW, Lin NH, Li Y, Daanen JF, Buccafusco JJ, Prendergast MA, Jackson WJ, Arneric SP.
    J Pharmacol Exp Ther; 1997 Oct 01; 283(1):247-58. PubMed ID: 9336330
    [Abstract] [Full Text] [Related]

  • 48. Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist.
    Damaj MI, Creasy KR, Welch SP, Rosecrans JA, Aceto MD, Martin BR.
    Psychopharmacology (Berl); 1995 Aug 01; 120(4):483-90. PubMed ID: 8539331
    [Abstract] [Full Text] [Related]

  • 49. In vitro pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a nicotinic acetylcholine receptor ligand.
    Rao TS, Adams PB, Correa LD, Santori EM, Sacaan AI, Reid RT, Suto CM, Vernier JM.
    Brain Res; 2003 Aug 15; 981(1-2):85-98. PubMed ID: 12885429
    [Abstract] [Full Text] [Related]

  • 50. Central nicotinic receptor agonists ABT-418, ABT-089, and (-)-nicotine reduce distractibility in adult monkeys.
    Prendergast MA, Jackson WJ, Terry AV, Decker MW, Arneric SP, Buccafusco JJ.
    Psychopharmacology (Berl); 1998 Mar 15; 136(1):50-8. PubMed ID: 9537682
    [Abstract] [Full Text] [Related]

  • 51. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
    Anderson DJ, Arneric SP.
    Eur J Pharmacol; 1994 Mar 03; 253(3):261-7. PubMed ID: 8200419
    [Abstract] [Full Text] [Related]

  • 52. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB, Grønlien JH, Kohlhaas KL, Nielsen EØ, Dam E, Jørgensen TD, Ahring PK, Peters D, Holst D, Christensen JK, Malysz J, Briggs CA, Gopalakrishnan M, Olsen GM.
    J Pharmacol Exp Ther; 2007 Oct 03; 323(1):294-307. PubMed ID: 17625074
    [Abstract] [Full Text] [Related]

  • 53. The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels.
    Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacott S, Aronstam RS, Albuquerque EX.
    J Pharmacol Exp Ther; 1990 Jul 03; 254(1):71-82. PubMed ID: 1694895
    [Abstract] [Full Text] [Related]

  • 54. Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.
    Briggs CA, McKenna DG, Piattoni-Kaplan M.
    Neuropharmacology; 1995 Jun 03; 34(6):583-90. PubMed ID: 7566493
    [Abstract] [Full Text] [Related]

  • 55. Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.
    Sullivan JP, Decker MW, Donnelly-Roberts D, Brioni JD, Bannon AW, Holladay MW, Anderson DJ, Briggs CA, Williams M, Arneric SP.
    Proc West Pharmacol Soc; 1995 Jun 03; 38():127-30. PubMed ID: 7480004
    [Abstract] [Full Text] [Related]

  • 56. Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons.
    Fu W, Jhamandas JH.
    J Neurophysiol; 2003 Nov 03; 90(5):3130-6. PubMed ID: 12890800
    [Abstract] [Full Text] [Related]

  • 57. Coupling of human nicotinic acetylcholine receptors alpha 7 to calcium channels in GH3 cells.
    Feuerbach D, Lingenhöhl K, Dobbins P, Mosbacher J, Corbett N, Nozulak J, Hoyer D.
    Neuropharmacology; 2005 Feb 03; 48(2):215-27. PubMed ID: 15695160
    [Abstract] [Full Text] [Related]

  • 58. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
    Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ.
    Mol Pharmacol; 1992 Jan 03; 41(1):31-7. PubMed ID: 1732720
    [Abstract] [Full Text] [Related]

  • 59. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y, Saito K, Imoto M, Ohno T.
    Eur J Pharmacol; 1998 Jun 19; 351(2):181-8. PubMed ID: 9687001
    [Abstract] [Full Text] [Related]

  • 60. In vivo pharmacological characterization of (+/-)-4-[2-(1-methyl-2-pyrrolidinyl)ethyl]thiophenol hydrochloride (SIB-1553A), a novel cholinergic ligand: microdialysis studies.
    Rao TS, Reid RT, Correa LD, Santori EM, Gardner MF, Sacaan AI, Lorrain D, Vernier JM.
    Brain Res; 2003 Oct 03; 986(1-2):71-81. PubMed ID: 12965231
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.